Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Insiders Buying Chart Industries And 2 Other Stocks

Published 18/12/2023, 12:39
Updated 18/12/2023, 13:40
© Reuters.  Insiders Buying Chart Industries And 2 Other Stocks

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Ooma

  • The Trade: Ooma, Inc. (NYSE: OOMA) CEO and President Eric B Stang acquired a total of 10,000 shares an average price of $9.85. To acquire these shares, it cost around $98,486.
  • What’s Happening: On Dec. 5, Ooma posted in-line earnings for its third quarter.
  • What Ooma Does: Ooma Inc is a United States-based provider of innovative communication solutions and other connected services to small business, home, and mobile users.
Chart Industries
  • The Trade: Chart Industries, Inc. (NYSE: GTLS) Director Linda Harty acquired a total of 1,000 shares at an average price of $130.14. To acquire these shares, it cost around $130,140.
  • What’s Happening: On Oct. 27, Chart Industries reported worse-than-expected third-quarter financial results and lowered full year 2023 sales guidance.
  • What Chart Industries Does: Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas (LNG) industries.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Kewaunee Scientific

  • The Trade: Kewaunee Scientific Corporation (NASDAQ: KEQU) Director John Russell bought a total of 7,500 shares at an average price of $22.98. To acquire these shares, it cost around $172,361.
  • What’s Happening: On Dec. 6, Kewaunee Scientific posted a profit for the second quarter.
  • What Kewaunee Scientific Does: Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products.

Check This Out: HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.